Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Top News
Top News
Health

ADHD Prescription Surge During Pandemic Fuels Lingering Supply Shortages

Adderall XR capsules are displayed on Feb. 24, 2023. Prescriptions for ADHD treatments surged among adults during the COVID-19 pandemic, helping to fuel lingering shortages that are frustrating parent

In the vast realm of healthcare, there are certain phenomena that leave us scratching our heads in bewilderment. One such enigma that has come to light during these tumultuous times is the surge in ADHD prescriptions among adults. Yes, you read that correctly! As if battling a global pandemic wasn't enough, it seems that adults everywhere have found solace in embracing their inner hyperactivity.

According to a recent study published in JAMA Psychiatry, new prescriptions for stimulant medications used to treat ADHD skyrocketed among young adults and women in the two-year period following the onset of the pandemic. Not only that, but prescriptions for nonstimulant treatments for adults of all ages also experienced a significant uptick. It's like the world collectively decided, 'Hey, let's just go all-in on ADHD treatments!'

Now, we know what you're thinking - how on Earth did this happen? Well, it seems that a combination of factors contributed to this unexpected surge. With telemedicine becoming more prominent, seeking help for ADHD became more convenient, and doctors even started prescribing medications without physically seeing their patients. Talk about efficiency!

But that's not all. Working from home seems to have played a role in this peculiar rise. As individuals found themselves in the comfort (or chaos) of their own environments, the veil was lifted, and many realized just how easily they got distracted. Parents, especially moms, were particularly quick to notice these traits in their children and began contemplating whether the apple had fallen far from the tree.

And let's not forget the power of social media. In this day and age, information travels at the speed of light, and awareness about adult ADHD was spread far and wide thanks to the ever-expanding realm of social networks. Suddenly, hashtags like #AdultingWithADHD became all the rage.

While this surge in ADHD treatments may seem like a blessing for those in need, it has unfortunately led to an unforeseen consequence - a shortage. Yes, you heard that right. The increased demand, coupled with manufacturing problems, has created a frustrating scarcity of medications like Adderall. Parents and doctors alike find themselves at their wits' end, desperately calling one pharmacy after another, only to be met with the disappointing message of 'out of stock.'

Just ask Wendy Terry from Diboll, Texas. With her third-grade son in desperate need of Focalin, she embarked on a pharmacy odyssey, calling nearly 20 establishments in search of the elusive medication. Finally, after a stroke of luck and an insider tip, she managed to find a drugstore that had a stash. But the anxiety of facing the refill nightmare looms over her, reminding her that this battle is far from over.

The underlying cause of these shortages is multifaceted. Federal regulations, due to the controlled substance nature of certain ADHD medications, limit their production. Regulators and drug manufacturers try their best to predict the demand based on past usage trends, but as we've learned, predicting the behavior of human beings is no easy feat. When usage experiences a sudden surge, shortages become an unfortunate consequence.

So here we are, amidst a perfect storm of ADHD prescriptions skyrocketing, supply dwindling, and frustrated parents and doctors caught in the crossfire. In the larger context of drug shortages, this is just the tip of the iceberg. With over 300 drug shortages recorded in the United States as of last fall, it's clear that this issue extends far beyond the realm of ADHD treatments. Chemotherapy drugs, vital for those fighting cancer, have also been subject to scarcity.

As we navigate these challenges, it's important to remember that no one is to blame. It's a complicated dance between supply and demand, with healthcare professionals doing their best to bridge the gap. Hopefully, in the coming months, solutions will arise, and the shortage scenario will become a footnote in the history of ADHD treatments.

But until then, let's take a moment to appreciate the creativity and resourcefulness of those embracing their inner hyperactivity. After all, in a world that constantly demands focus and attention, maybe a little ADHD isn't such a bad thing. Just as long as we remember to refill those prescriptions in a timely manner!

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.